Public source

Reviewed 21 Jul 2026

Completeness Fair (39%)

DeepDx Prostate CNB

Deep Bio

DeepDx® Prostate is a clinically validated and CE-marked AI diagnostic support software for prostate cancer. The software analyzes digitized slide images of Hematoxylin & Eosin (H&E) stained prostate specimens to detect and localize areas of interest. These areas of interest are detected based on their severity in accordance with the Gleason Scoring System.

Supported by 3 papers

General Information

Product name

DeepDx Prostate CNB

Company

Modality

Histopathology

Main task

Detection, Grading

Subspeciality

Uropathology

Organ/Specimen source

Not specified

Disease targeted

Prostate cancer

Specimen type

Biopsy

Staining

H&E

Stain subtype

Not specified

Regulatory Information

CE-IVD Certification

Pathway:

In Vitro Diagnostic Directive (IVDD)

Class:

General IVD Devices

Not verified by Health AI Register

Scanner Brands Certified for Use (CE-IVD)

Not specified

Scanner Models Certified for Use (CE-IVD)

Not specified

Other certifications

Not specified

Technical Specifications

Patient population age

Not specified

Input

Not specified

Input format

Not specified

Output

Not specified

Output format

Not specified

Integration

Not specified

Deployment

Cloud-based, On-premise

Trigger for analysis

Not specified

Processing time

10 - 60 seconds

Population

Not specified

Viewer systems

Not specified

Market Presence

On market since

Not specified

AI Platforms

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Not specified

Based on

Not specified

Source: Public | First published: Aug 1, 2025 | Last updated: Jul 21, 2026

DeepDx Prostate CNB - Deep Bio